You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Alembic Ltd Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ALEMBIC LTD, and what generic and branded alternatives to ALEMBIC LTD drugs are available?

ALEMBIC LTD has two approved drugs.



Summary for Alembic Ltd
US Patents:0
Tradenames:2
Ingredients:2
NDAs:2
Drug Master File Entries: 2

Drugs and US Patents for Alembic Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Ltd ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 090429-005 Mar 24, 2010 AB RX No No ⤷  Subscribe ⤷  Subscribe
Alembic Ltd LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 079159-003 Jan 12, 2009 AB RX No No ⤷  Subscribe ⤷  Subscribe
Alembic Ltd ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 090429-006 Mar 24, 2010 AB RX No No ⤷  Subscribe ⤷  Subscribe
Alembic Ltd ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 090429-007 Mar 24, 2010 AB RX No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.